Related Experiment Video
Updated: Aug 13, 2026

Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells
Published on: February 21, 2014
Heregulin-beta1 regulates the estrogen receptor-alpha gene expression and activity via the ErbB2/PI 3-K/Akt pathway
Gerald E Stoica1, Thomas F Franke, Anton Wellstein
1Department of Oncology, Lombardi Cancer Center, Georgetown University, Washington, DC 20007, USA.
Abstract:
This study examines whether the serine/threonine protein kinase, Akt, is involved in the crosstalk between the ErbB2 and estrogen receptor-alpha (ER-alpha) pathways. Treatment of MCF-7 cells with 10(-9) M heregulin-beta1 (HRG-beta1) resulted in a rapid phosphorylation of Akt and a 15-fold increase in Akt activity. Akt phosphorylation was blocked by inhibitors of phosphatidylinositol 3-kinase (PI 3-K), by antiestrogens, the protein tyrosine kinase inhibitor, genistein, and by AG825, a selective ErbB2 inhibitor; but not by AG30, a selective EGFR inhibitor. Akt phosphorylation by HRG-beta1 was abrogated by an arginine to cysteine mutation (R25C) in the pleckstrin homology (PH) domain of Akt, and HRG-beta1 did not induce Akt phosphorylation in the ER-negative variant of MCF-7, MCF-7/ADR. Transient transfection of ER-alpha into these cells restored Akt phosphorylation by HRG-beta1, suggesting the requirement of ER-alpha. HRG-beta1 did not activate Akt in MCF-7 cells stably transfected with an anti-ErbB2-targeted ribozyme, further confirming a role for ErbB2. Stable transfection of the cells with a dominant negative Akt or with the R25C-Akt mutant, as well as PI 3-K inhibitors, blocked the effect of HRG-beta1 on ER-alpha expression and activity and on the growth of MCF-7 cells. Stable transfection of MCF-7 cells with a constitutively active Akt mimicked the effect of HRG-beta1. Experiments employing selective ErbB inhibitors demonstrate that the effect of HRG-beta1 on ER-alpha expression and activity is also mediated by ErbB2 and not by EGFR, demonstrating that ErbB2 is the primary mediator of the effects of HRG-beta1 on ER-alpha regulation. Taken together, our data suggest that HRG-beta1, bound to the ErbB2 ErbB3 heterodimer, in the presence of membrane ER-alpha, interacts with and activates PI 3-K/Akt. Akt leads to nuclear ER-alpha phosphorylation, thereby altering its expression and transcriptional activity.
Insights
The serine/threonine protein kinase, Akt, mediates crosstalk between ErbB2 and estrogen receptor-alpha (ER-alpha) pathways. Heregulin-beta1 activates Akt, which then phosphorylates ER-alpha, impacting its activity and cell growth.
Area of Science:
- Molecular Biology
- Cell Signaling
- Cancer Research
Background:
- Crosstalk between ErbB2 and estrogen receptor-alpha (ER-alpha) pathways is crucial in cancer progression.
- The role of serine/threonine protein kinase, Akt, in this crosstalk is not fully understood.
Purpose of the Study:
- To investigate the involvement of Akt in the crosstalk between ErbB2 and ER-alpha signaling pathways.
- To elucidate the mechanism by which heregulin-beta1 (HRG-beta1) influences ER-alpha activity via Akt.
Main Methods:
- Utilized MCF-7 cells and their variants, including ER-negative and ErbB2-inhibited lines.
- Employed HRG-beta1 treatment and inhibitors of phosphatidylinositol 3-kinase (PI 3-K), ErbB2, and EGFR.
- Assessed Akt phosphorylation and activity, ER-alpha expression and activity, and cell growth through transfections with Akt mutants and constitutively active Akt.
Main Results:
- HRG-beta1 rapidly induced Akt phosphorylation and activity, dependent on ErbB2 and ER-alpha.
- Akt activation by HRG-beta1 was mediated by PI 3-K and required the pleckstrin homology (PH) domain of Akt.
- Inhibition of Akt or PI 3-K blocked HRG-beta1's effects on ER-alpha activity and cell growth; constitutively active Akt mimicked HRG-beta1's effects.
Conclusions:
- Akt acts as a key mediator in the crosstalk between HRG-beta1/ErbB2 and ER-alpha signaling.
- HRG-beta1 activates Akt, which subsequently phosphorylates ER-alpha, altering its expression and transcriptional activity.
- Targeting the PI 3-K/Akt pathway could be a therapeutic strategy for cancers involving ErbB2 and ER-alpha signaling.
Related Concept Videos
Hedgehog Signaling Pathway
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Regulation of Angiogenesis and Blood Supply
TGF - β Signaling Pathway
GPCRs Regulate Adenylyl Cylase Activity
Two...
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:

